171 related articles for article (PubMed ID: 35815815)
1. Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor.
Kralova B; Sochorcova L; Song J; Jahoda O; Hlusickova Kapralova K; Prchal JT; Divoky V; Horvathova M
Am J Hematol; 2022 Oct; 97(10):1286-1299. PubMed ID: 35815815
[TBL] [Abstract][Full Text] [Related]
2. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietic regulators of iron metabolism.
Ganz T
Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly.
Gammella E; Diaz V; Recalcati S; Buratti P; Samaja M; Dey S; Noguchi CT; Gassmann M; Cairo G
Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R330-5. PubMed ID: 25519735
[TBL] [Abstract][Full Text] [Related]
5. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
[TBL] [Abstract][Full Text] [Related]
6. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
[TBL] [Abstract][Full Text] [Related]
7. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D
Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707
[TBL] [Abstract][Full Text] [Related]
8. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.
Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
J Nutr; 2021 Jul; 151(7):1824-1833. PubMed ID: 33982118
[TBL] [Abstract][Full Text] [Related]
9. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
Zaman BA; Rasool SO; Abdo JM
Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
[TBL] [Abstract][Full Text] [Related]
10. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure.
Robach P; Gammella E; Recalcati S; Girelli D; Castagna A; Roustit M; Lundby C; Lundby AK; Bouzat P; Vergès S; Séchaud G; Banco P; Uhr M; Cornu C; Sallet P; Cairo G
Haematologica; 2021 Feb; 106(2):384-390. PubMed ID: 31919080
[TBL] [Abstract][Full Text] [Related]
11. The second transferrin receptor regulates red blood cell production in mice.
Nai A; Lidonnici MR; Rausa M; Mandelli G; Pagani A; Silvestri L; Ferrari G; Camaschella C
Blood; 2015 Feb; 125(7):1170-9. PubMed ID: 25499454
[TBL] [Abstract][Full Text] [Related]
12. Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples.
Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
J Nutr; 2021 Sep; 151(9):2590-2600. PubMed ID: 34236433
[TBL] [Abstract][Full Text] [Related]
13. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.
Srole DN; Ganz T
J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284
[TBL] [Abstract][Full Text] [Related]
14. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
15. A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
Olivari V; Di Modica SM; Lidonnici MR; Aghajan M; Cordero-Sanchez C; Tanzi E; Pettinato M; Pagani A; Tiboni F; Silvestri L; Guo S; Ferrari G; Nai A
Kidney Int; 2023 Jul; 104(1):61-73. PubMed ID: 36990212
[TBL] [Abstract][Full Text] [Related]
16. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
Olivera J; Zhang V; Nemeth E; Ganz T
Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
[TBL] [Abstract][Full Text] [Related]
17. Characterization of erythroferrone structural domains relevant to its iron-regulatory function.
Srole DN; Jung G; Waring AJ; Nemeth E; Ganz T
J Biol Chem; 2023 Dec; 299(12):105374. PubMed ID: 37866631
[TBL] [Abstract][Full Text] [Related]
18. Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice.
Nakai T; Iwamura Y; Kato K; Hirano I; Matsumoto Y; Tomioka Y; Yamamoto M; Suzuki N
Blood Adv; 2023 Aug; 7(15):3793-3805. PubMed ID: 37146271
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development.
Yoon D; Pastore YD; Divoky V; Liu E; Mlodnicka AE; Rainey K; Ponka P; Semenza GL; Schumacher A; Prchal JT
J Biol Chem; 2006 Sep; 281(35):25703-11. PubMed ID: 16787915
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.
Pinto JP; Ribeiro S; Pontes H; Thowfeequ S; Tosh D; Carvalho F; Porto G
Blood; 2008 Jun; 111(12):5727-33. PubMed ID: 18326822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
